Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 1,169 | 996 | 1,164 | 772 | 1,070 |
| Cost of Goods | 2,424 | 1,980 | 1,809 | 273 | 366 |
| Gross Profit | -1,255 | -984 | -645 | 499 | 703 |
| Operating Expenses | 1,563 | 2,694 | 2,393 | 3,293 | 3,938 |
| Operating Income | -2,394 | -2,699 | -2,230 | -2,521 | -2,868 |
| Interest Expense | 1,434 | 977 | 999 | 210 | 83 |
| Other Income | 0 | -3 | -182 | 59 | -54 |
| Pre-tax Income | -3,829 | -3,678 | -3,411 | -2,672 | -3,004 |
| Net Income Continuous | -3,829 | -3,678 | -3,411 | -2,672 | -3,004 |
| Net Income | $-3,829 | $-3,678 | $-3,411 | $-2,672 | $-3,004 |
| EPS Basic Total Ops | -0.13 | -0.13 | -0.15 | -0.16 | -0.20 |
| EPS Basic Continuous Ops | -0.13 | -0.13 | -0.15 | -0.16 | -0.20 |
| EPS Diluted Total Ops | -0.13 | -0.13 | -0.15 | -0.16 | -0.20 |
| EPS Diluted Continuous Ops | -0.13 | -0.13 | -0.15 | -0.16 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.13 | -0.14 | N/A | -0.20 |
| EBITDA(a) | $-1,553 | $-2,279 | $-1,995 | $-2,510 | $-2,853 |